...
首页> 外文期刊>American Journal of Physiology >Young SHR express increased type 1 angiotensin II receptors in renal proximal tubule.
【24h】

Young SHR express increased type 1 angiotensin II receptors in renal proximal tubule.

机译:年轻的SHR在肾近端小管中表达增加的1型血管紧张素II受体。

获取原文
获取原文并翻译 | 示例

摘要

A potential role for the renin-angiotensin system (RAS) in the development and/or maintenance of hypertension in the genetic model of rat hypertension, spontaneously hypertensive rats (SHR), has been suggested by studies indicating that treatment of immature animals with angiotensin-converting enzyme (ACE) inhibitors prevents subsequent development of hypertension. Because young SHR also demonstrate RAS-dependent increased sodium retention, we examined proximal tubule type 1 angiotensin II receptor (AT1R) mRNA expression in young (4 wk) or adult (14 wk) SHR compared with age-matched Wistar-Kyoto (WKY) rats. Proximal tubules were isolated by Percoll gradient centrifugation, and AT1R mRNA expression was measured by quantitative reverse transcription-polymerase chain reaction (RT-PCR). At 14 wk, when SHR had established hypertension [mean arterial blood pressure (MAP) of SHR vs. WKY: 145 +/- 6 vs. 85 +/- 5 mmHg, n = 14-15], there were no differences in proximal tubule AT1R mRNA levels [SHR vs. WKY: 79 +/- 14 vs. 72 +/- 14 counts/min (cpm) per cpm mutant AT1R per cpm beta-actin x 10(-6), n = 6; not significant (NS)]. In contrast, in 4 wk SHR, at a time of minimal elevations in blood pressure (MAP: 70 +/- 8 vs. 63 +/- 3), SHR proximal tubule AT1R mRNA levels were 263 +/- 30% that of WKY (143 +/- 18 vs. 60 +/- 11 cpm per cpm of mutant AT1R per cpm beta-actin x 10(-6), n = 8; P < 0.005). We have recently shown that chronic ACE inhibition decreases proximal tubule AT1R expression and have also shown that chronic L-3,4-dihydroxyphenylalamine (L-DOPA) administration inhibits AT1R expression in adult Sprague-Dawley proximal tubule and cultured proximal tubule, and this inhibition is mediated via Gs-coupled DA1 receptors. When 3-wk-old animals were given L-DOPA or captopril for 1 wk, MAP was not altered (70 +/- 8 vs. 60 +/- 4 or 61 +/- 5 mmHg), but proximal tubule AT1R mRNA was no longer significantly different between SHR and WKY (68 +/- 9 vs. 38 +/- 7 or 20 +/- 3 vs. 47 +/- 15 cpm per cpm of mutant AT1R per cpm beta-actin x 10(-6)), due to a significant decrease in proximal tubule AT1R expression in SHR (P < 0.005, compared with untreated SHR). Immunoreactive proximal tubule AT1R expression also was increased in 4 wk SHR and was reversed with captopril or L-DOPA treatment. Therefore, these results indicate that young, but not adult, SHR have increased expression of proximal tubule AT1R and that chronic L-DOPA or captopril treatment decreased the elevated AT1R expression to control levels. These results provide further support for an important role of the RAS in the development of hypertension in SHR.
机译:研究表明,用血管紧张素-二磷酸治疗未成熟动物,肾素-血管紧张素系统(RAS)在大鼠高血压遗传模型(自发性高血压大鼠(SHR))中在高血压的发展和/或维持中的潜在作用。转换酶(ACE)抑制剂可预防高血压的后续发展。因为年轻的SHR还显示出RAS依赖性的钠保留增加,所以我们检查了年轻(4周)或成人(14周)SHR与年龄匹配的Wistar-Kyoto(WKY)相比,近端小管1型血管紧张素II受体(AT1R)mRNA表达大鼠。通过Percoll梯度离心分离近端小管,并通过定量逆转录-聚合酶链反应(RT-PCR)测量AT1R mRNA表达。在第14周时,SHR建立了高血压[SHR与WKY的平均动脉压(MAP):145 +/- 6 vs. 85 +/- 5 mmHg,n = 14-15],近端无差异小管AT1R mRNA水平[SHR与WKY:每cpm突变体AT1R每cpmβ-肌动蛋白x 10(-6)的79 +/- 14 vs. 72 +/- 14计数/分钟(cpm),n = 6;不重要(NS)]。相反,在4周的SHR中,在血压最小升高的时间(MAP:70 +/- 8对63 +/- 3),SHR近端小管AT1R mRNA水平是WKY的263 +/- 30% (每cpmβ-肌动蛋白x 10(-6)突变AT1R每cpm 143 +/- 18 vs. 60 +/- 11 cpm,n = 8; P <0.005)。我们最近发现,慢性ACE抑制作用会降低近端小管AT1R的表达,并且还表明,长期施用L-3,4-二羟基苯丙胺(L-DOPA)可以抑制成年Sprague-Dawley近端小管和培养的近端小管中的AT1R表达。通过Gs偶联的DA1受体介导。 3周大的动物接受L-DOPA或卡托普利治疗1周时,MAP不变(70 +/- 8 vs. 60 +/- 4或61 +/- 5 mmHg),但近端小管AT1R mRNA SHR和WKY之间的差异不再显着(68 +/- 9 vs.38 +/- 7或20 +/- 3 vs. 47 +/- 15 cpm每cpm突变AT1R每cpmβ-肌动蛋白x 10(-6 )),这是由于SHR中近端小管AT1R表达显着降低(与未经治疗的SHR相比,P <0.005)。免疫反应性近端小管AT1R表达在4 wk SHR中也有所增加,卡托普利或L-DOPA治疗可逆转。因此,这些结果表明,年轻但非成年人的SHR增加了近端小管AT1R的表达,并且长期的L-DOPA或卡托普利治疗将升高的AT1R表达降低至对照水平。这些结果为RAS在SHR高血压发展中的重要作用提供了进一步的支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号